U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    LDLR low density lipoprotein receptor [ Homo sapiens (human) ]

    Gene ID: 3949, updated on 2-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Association between Apo B, LDL-R and PCSK9 gene polymorphisms with coronary artery diseases in Egyptians.

    Association between Apo B, LDL-R and PCSK9 gene polymorphisms with coronary artery diseases in Egyptians.
    Mahsoub N, Almenshawy A, Taki Eldin AM, Abdel Hay NM, Youssef AR, El-Farahaty RM, El-Sayed K, Osman AM, Elhennawy ES.

    09/20/2024
    Insights into PCSK9-LDLR Regulation and Trafficking via the Differential Functions of MHC-I Proteins HFE and HLA-C.

    Insights into PCSK9-LDLR Regulation and Trafficking via the Differential Functions of MHC-I Proteins HFE and HLA-C.
    Mikaeeli S, Ben Djoudi Ouadda A, Evagelidis A, Essalmani R, Ramos OHP, Fruchart-Gaillard C, Seidah NG., Free PMC Article

    09/10/2024
    Methylation status of LDLR, PCSK9 and LDLRAP1 is associated with cardiovascular events in familial hypercholesterolemia.

    Methylation status of LDLR, PCSK9 and LDLRAP1 is associated with cardiovascular events in familial hypercholesterolemia.
    Silva Rodrigues Marçal ED, Borges JB, Bastos GM, Crespo Hirata TD, de Oliveira VF, Gonçalves RM, Faludi AA, Dias França JI, de Oliveira Silva DV, Malaquias VB, Luchessi AD, Silbiger VN, Nakazone MA, Carmo TS, Silva Souza DR, Sampaio MF, Crespo Hirata RD, Hirata MH.,

    09/4/2024
    Phenotypic characterization and predictive analysis of p.Asp47Asn LDL receptor mutation associated with Familial Hypercholesterolemia in a Chilean population.

    Phenotypic characterization and predictive analysis of p.Asp47Asn LDL receptor mutation associated with Familial Hypercholesterolemia in a Chilean population.
    Sánchez A, Bustos P, Honorato P, Burgos CF, Barriga N, Jannes CE, Sáez K, Alonso R, Asenjo S, Radojkovic C.

    07/26/2024
    LDLR c.89_92dup: a novel frameshift variation in familial hypercholesterolemia.

    LDLR c.89_92dup: a novel frameshift variation in familial hypercholesterolemia.
    Deng J, Zhang J, Meng S, Ding N, Hao Y, Zeng H, Lin J., Free PMC Article

    06/26/2024
    Impact of LDLR polymorphisms on lipid levels and atorvastatin's efficacy in a northern Chinese adult Han cohort with dyslipidemia.

    Impact of LDLR polymorphisms on lipid levels and atorvastatin's efficacy in a northern Chinese adult Han cohort with dyslipidemia.
    Zhao HL, You Y, Tian Y, Wang L, An Y, Zhang G, Shu C, Yu M, Zhu Y, Li Q, Zhang Y, Sun N, Hu S, Liu G., Free PMC Article

    05/3/2024
    High Prevalence of Familial Hypercholesterolemia Due to the Founder Effect of the LDLR c.2271del Variant in Communities of Oaxaca, Mexico.

    High Prevalence of Familial Hypercholesterolemia Due to the Founder Effect of the LDLR c.2271del Variant in Communities of Oaxaca, Mexico.
    Rodríguez-Gutiérrez PG, Hernández-Flores TJ, Zepeda-Olmos PM, Reyes-Rodríguez CD, Robles-Espinoza K, Solís-Gómez U, González-García JR, Magaña-Torres MT.

    04/25/2024
    Identification of a novel LDLR p.Glu179Met variant in Thai families with familial hypercholesterolemia and response to treatment with PCSK9 inhibitor.

    Identification of a novel LDLR p.Glu179Met variant in Thai families with familial hypercholesterolemia and response to treatment with PCSK9 inhibitor.
    Pussadhamma B, Wongvipaporn C, Wutthimanop A, Nuinoon M, Porntadavity S, Jeenduang N., Free PMC Article

    03/27/2024
    A case report of an Egyptian family with familial hypercholesterolemia and an exonic LINE-1 insertion in LDLR.

    A case report of an Egyptian family with familial hypercholesterolemia and an exonic LINE-1 insertion in LDLR.
    Song Y, Elwafa RAHA, Omar OM, Seo GH, Lee H., Free PMC Article

    03/6/2024
    Novel LDLR variants affecting low density lipoprotein metabolism identified in familial hypercholesterolemia.

    Novel LDLR variants affecting low density lipoprotein metabolism identified in familial hypercholesterolemia.
    Wang M, Hong L, Cai L, Zhang Z, Jiang N, Chen Y, Ying Q, Kong L, Wei Z, Xu Y, Jin L.

    02/7/2024
    LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus.

    LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus.
    Xu ZS, Du WT, Wang SY, Wang MY, Yang YN, Li YH, Li ZQ, Zhao LX, Yang Y, Luo WW, Wang YY., Free PMC Article

    02/6/2024
    iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia.

    iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia.
    Zakharova IS, Shevchenko AI, Arssan MA, Sleptcov AA, Nazarenko MS, Zarubin AA, Zheltysheva NV, Shevchenko VA, Tmoyan NA, Saaya SB, Ezhov MV, Kukharchuk VV, Parfyonova YV, Zakian SM., Free PMC Article

    01/31/2024
    Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia.

    Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia.
    Lv X, Wang C, Liu L, Yin G, Zhang W, Abdu FA, Shi T, Zhang Q, Che W., Free PMC Article

    11/30/2023
    Identification and functional characterization of two rare LDLR stop gain variants (p.C231* and p.R744*) in Saudi familial hypercholesterolemia patients.

    Identification and functional characterization of two rare LDLR stop gain variants (p.C231* and p.R744*) in Saudi familial hypercholesterolemia patients.
    Awan Z, Batran A, Al-Allaf FA, Alharbi RS, Hegazy GA, Jamalalail B, Almansouri M, Bima AI, Almukadi H, Kutbi HI, Altayar AE, Banaganapalli B, Shaik NA.

    11/29/2023
    The LDL receptor is regulated by membrane cholesterol as revealed by fluorescence fluctuation analysis.

    The LDL receptor is regulated by membrane cholesterol as revealed by fluorescence fluctuation analysis.
    Morales SV, Mahmood A, Pollard J, Mayne J, Figeys D, Wiseman PW., Free PMC Article

    09/23/2023
    Proteolysis of the low-density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases.

    Proteolysis of the low-density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases.
    Kellett KAB, Fisher K, Aldworth H, Hooper NM., Free PMC Article

    08/25/2023
    Novel Tools for Comprehensive Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants.

    Novel Tools for Comprehensive Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants.
    Jasiecki J, Targońska M, Janaszak-Jasiecka A, Chmara M, Żuk M, Kalinowski L, Waleron K, Wasąg B., Free PMC Article

    08/16/2023
    LDLR promotes autophagy-mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway.

    LDLR promotes autophagy-mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway.
    Liu L, Sun YH, An R, Cheng RJ, Li N, Zheng JH.

    08/16/2023
    Linkage Disequilibrium between LDLR rs688 and AvaII Genes and its Significant Association with Ischemic Stroke.

    Linkage Disequilibrium between LDLR rs688 and AvaII Genes and its Significant Association with Ischemic Stroke.
    Chen Y, Cai H, Zhang J, Su Y, Wu Y, Lin Z, Zhang Z.

    08/4/2023
    Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells.

    Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells.
    Uppal S, Postnikova O, Villasmil R, Rogozin IB, Bocharov AV, Eggerman TL, Poliakov E, Redmond TM., Free PMC Article

    08/3/2023
    A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD.

    A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD.
    Srivastava RAK., Free PMC Article

    07/5/2023
    Identification and Molecular Characterization of a Novel Large-Scale Variant (Exons 4_18 Loss) in the LDLR Gene as a Cause of Familial Hypercholesterolaemia in an Italian Family.

    Identification and Molecular Characterization of a Novel Large-Scale Variant (Exons 4_18 Loss) in the LDLR Gene as a Cause of Familial Hypercholesterolaemia in an Italian Family.
    Concolino P, De Paolis E, Moffa S, Onori ME, Soldovieri L, Ricciardi Tenore C, De Bonis M, Rabacchi C, Santonocito C, Rinelli M, Calandra S, Giaccari A, Urbani A, Minucci A., Free PMC Article

    06/30/2023
    In vitro assessment of the pathogenicity of the LDLR c.2160delC variant in familial hypercholesterolemia.

    In vitro assessment of the pathogenicity of the LDLR c.2160delC variant in familial hypercholesterolemia.
    Lin S, Hu T, Wang K, Wang J, Zhu Y, Chen X., Free PMC Article

    06/28/2023
    Exosomal circ_0008285 in follicle fluid regulates the lipid metabolism through the miR-4644/ LDLR axis in polycystic ovary syndrome.

    Exosomal circ_0008285 in follicle fluid regulates the lipid metabolism through the miR-4644/ LDLR axis in polycystic ovary syndrome.
    Yu L, Wang C, Zhang D, Liu M, Liu T, Pan B, Che Q, Liu S, Wang B, Dong X, Guo W., Free PMC Article

    06/24/2023
    Association of LDLR, TP53 and MMP9 Gene Polymorphisms With Atherosclerosis in a Malaysian Study Population.

    Association of LDLR, TP53 and MMP9 Gene Polymorphisms With Atherosclerosis in a Malaysian Study Population.
    Ahmad Z, Blin J, Rampal L, Adnan RS, Mohtarrudin N, Abang Yusuf DSY.

    05/4/2023
    firstprevious page of 23 nextlast